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Abstract 
Background: Outpatient oncology clinics are complex environments. The multi-step, sequential 
nature of oncology treatment contributes to delays. Prolonged wait time impacts patient 
compliance, satisfaction, and staff satisfaction. 
Objectives: To assess throughput in the outpatient pediatric oncology clinic and explore staff’s 
assessment of throughput and their opinions of what might be improved. 
Methods: Our descriptive-comparative study used retrospective reviews to measure four time 
intervals for 312 visits at our mid-Atlantic outpatient clinic. Patient and appointment factors were 
explored. Mean interval times were calculated and differences impacting throughput were 
analyzed using ANOVA. Prospective survey data were obtained from 22 clinic staff and themes 
were identified. 
Results: The shortest interval was check-in to triage (18.49 ± 18.21 minutes) while the longest 
was from receiving laboratory results to treatment initiation (136.73 ± 77.98 minutes). 
Throughput was significantly shorter for appointments consisting of provider visit and laboratory 
studies only compared to visits involving infusions and blood product transfusions (p < .001). 
Throughput for 8:00-10:00 a.m. appointments was significantly longer than 2:01-6:00 p.m. 
appointments (p = .013). Staff respondents reported throughput was suboptimal. Common 
problems identified were appointment noncompliance, laboratory workflow, triage and front desk 
bottlenecks, physician timeliness, fellow workflow, and “saving seats”.  
Conclusions: Delays occurred at each clinic intersection but were significantly longer with early 
clinic appointments and infusion and transfusion visits. Staff highlighted problems at each clinic 
juncture and overarching problems that caused inefficiencies. We identified priority areas to be 
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Background 
There is a clear trend in the current health care system to provide cost-effective oncology 
care and chemotherapy treatment in the outpatient setting (Hendershot et al., 2005; Reid et al., 
2016). Outpatient oncology clinics are complex environments in which many health care 
professionals must coordinate aspects of medical treatment to provide patients with safe and 
high-quality care (Suss, Bhuiyan, Demirli, & Batist, 2017). Oncology treatment and 
chemotherapy administration are multistep, sequential, interdisciplinary processes which involve 
several activities that must be completed prior to the patient receiving therapy. These include 
check-in, triage and vital sign assessment, accessing the central venous catheter (CVC) or 
obtaining peripheral intravenous (IV) access, drawing laboratory studies and awaiting results, 
assessment by the medical provider, and preparation, delivery, and administration of the 
chemotherapy, blood product, or other infusion (Belter et al., 2012). These activities occur 
consecutively and are contingent upon one step being completed before the next. This complex 
process may cause patients to experience delays and extended wait times in the clinic. Prolonged 
wait times can influence patients’ perception of the quality of care, negatively affect compliance, 
and impact satisfaction (Davis, Burrows, Khallouq, & Rosen, 2017; Gjolaj, Campos, Olier-Pino, 
& Fernandez, 2016). Studies have also shown that extended wait times increase emotional 
turmoil and psychological burden for cancer patients (Gourdji, McVey, & Loiselle, 2003). 
 Many outpatient cancer centers have conducted research exploring approaches to reduce 
wait times and improve efficiency in patient throughput. Implementation of new scheduling 
methods aimed at maximizing resource utilization have shown promise at several institutions 
(Ahmed, ElMekkawy, & Bates, 2011; Suss et al., 2017; Woodall, Gosselin, Boswell, Murr, & 
Denton, 2013). Another approach involves drawing laboratory studies the day prior to 
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chemotherapy to expedite treatment the following day (De Pourcq, Gemmel, Trybou, & Kruse, 
2018; Dobish, 2003; Suss et al., 2017). Streamlining communication processes through 
development of standardized practice procedures has also shown success (Belter et al., 2012). 
Other approaches include implementation of fast track areas to improve efficiency for patients 
with short infusions or procedures (Kallen, Terrell, Lewis-Patterson, & Hwang, 2012). Each 
cancer center is structured differently and the chosen method to improve patient throughput must 
address the specific issues and needs of that clinic. However, the first step to improve patient 
throughput is to conduct a thorough evaluation of patient flow and identify which areas of the 
clinic contribute to delays and inefficiency (Belter et al., 2012) so that targeted interventions can 
be implemented to improve throughput.  
Problem Statement 
Patients often encounter delays at our outpatient pediatric hematology, oncology, and 
bone marrow transplant (BMT) clinic. Prolonged wait time was the issue most frequently cited 
on patient satisfaction surveys at our institution. Patients often reported that they arrived on time 
for their appointment but waited for an extended period before the visit began. Another common 
statement was that patients waited a long time for their chemotherapy to be ready. One patient 
experience survey question specifically asks if patients were kept informed of their wait time. 
This question was the lowest scoring domain at our pediatric cancer center.  
Our nursing staff also identified patient throughput as a major issue that impaired overall 
clinic functionality. Inefficient processes often lead to disorganized patient flow and congestion, 
which puts added stress on nursing and support staff to complete tasks for several patients 
simultaneously. This pressure in combination with managing patient dissatisfaction has been 
linked to reduced job satisfaction and decreased staff commitment to the organization (Rondeau, 
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1998). Patient throughput in the pediatric hematology, oncology, and BMT clinic is associated 
with patient satisfaction, staff satisfaction, and patient outcomes. Further investigation of this 
topic was warranted to gain an understanding of the specific issues that contributed to throughput 
delays in our clinic to develop a targeted action plan for improvement.  
Purpose 
The purpose of our study was to assess patient throughput times in the outpatient 
pediatric hematology, oncology, and BMT clinic at a large teaching hospital in the mid-Atlantic 
region. A secondary purpose was to explore the staff’s overall assessment of patient throughput 
and their opinions of what might improve throughput.  
Aims 
The specific aims of our study were to: 
1. Evaluate patient throughput in the pediatric hematology, oncology and BMT clinic using 
the following time intervals: 
a. Time from check-in to triage. 
b. Time from triage to receiving laboratory results. 
c. Time from receiving laboratory results to treatment initiation. 
d. Total throughput time. 
2. Explore clinic staff’s overall assessment of patient throughput. 
3. Explore clinic staff’s opinion of what might improve patient throughput.  
Research Questions 
We assessed the following research questions: 
For patients scheduled at an outpatient pediatric hematology, oncology, and BMT clinic:  
1. What is the average time from check-in to triage? 
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2. What is the average time from triage to receiving laboratory results? 
3. What is the average time from receiving laboratory results to treatment initiation? 
4. What is the average total throughput time? 
5. Is there a difference in total throughput time based on the type of appointment? 
6. Is there a difference in total throughput time based on time of the appointment? 
7. What is the clinic staff’s overall assessment of patient throughput? 
8. What are the clinic staff ‘s opinions about what might be done to improve patient 
throughput?  
Significance 
Effective patient throughput is essential to achieve and maintain efficiency in outpatient 
pediatric cancer centers. Optimizing processes for patient flow is an important initiative for 
healthcare institutions, as it directly impacts productivity, patient satisfaction, and compliance 
(Davis et al., 2017; Gjolaj et al., 2016). Patient experience is a top priority, especially since the 
Centers for Medicare and Medicaid Services (2017) executed the Hospital Value-Based 
Purchasing Program wherein reimbursement is contingent upon quality measures, one of which 
is patient experience. Patient satisfaction has been closely tied to wait time which is impacted by 
throughput (Davis et al., 2017; Matthews, Ryan, & Bulman, 2015). A thorough understanding of 
patient flow is required to effectively approach throughput issues (Gjolaj et al., 2016).  
Our study took the crucial first step of evaluating patient throughput to identify factors 
and clinic intersections that contribute to significant delays. Based on the findings of the 
assessment, a targeted action plan was developed to improve throughput in the clinic. The 
findings from this study will add to the body of knowledge about factors that contribute to 
extended wait times and inefficiency in pediatric oncology clinics. These findings may also be 
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generalizable to other outpatient centers. Additionally, the process of evaluation, the conclusions, 
as well as the action plan can help to guide our clinic as well as others in developing process 
improvement plans to optimize throughput.  
Literature Review 
Search Strategy 
A literature search was conducted between November 2017 and November 2018 to 
address the research questions. The databases used for the search included CINAHL Plus, 
Medline Complete, PubMed, and Scopus. These databases were accessed through the 
Himmelfarb Health Sciences Library through The George Washington University. Keywords 
used in the searches included outpatient, oncology, wait time, patient throughput, patient 
satisfaction, and simulation. The Boolean operator “AND” was used with the keywords. Because 
of limited literature on process mapping and clinic throughput evaluation, the limitation for date 
range was set at 15 years for each search.  
Inclusion and Exclusion Criteria 
Inclusion criteria applied included (a) written in the English language, (b) published 
within the past 15 years, (c) adult and pediatric oncology population, and (d) outpatient setting.
 Exclusion criteria included (a) inpatient setting and (b) non-oncology population. 
Literature Search Results 
A total of 218 articles were identified through literature searches and an additional 39 
articles were identified through the reference lists of articles, making a total of 257. After 
duplicates were identified and removed, there were 137 records available, of which all titles and 
abstracts were reviewed. Articles were included and excluded based on the outlined criteria. 
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A recurrent theme in the literature review was that outpatient oncology clinics have a 
finite number of treatment chairs and resources, which makes patient throughput an essential 
focus to optimize clinic efficiency. To develop a targeted action plan aimed at improving patient 
throughput, there must be a thorough patient flow assessment from entry to discharge. The 
evaluation should analyze each step of the patient visit to identify specific events which 
contribute to delays (Gjolaj et al., 2016). Many outpatient oncology clinics have implemented 
initiatives to improve patient throughput based on information obtained from the assessment of 
clinic flow pre-intervention (Belter et al., 2012; Dobish, 2003; Gjolaj et al., 2016; Gjolaj, Gari, 
Olier-Pino, Garcia, & Fernandez 2014; Kallen et al., 2012; Skledon et al., 2014). Most 
assessments have revealed multiple factors that lead to delays.  
 Hendershot et al. (2015) developed a task force which reviewed the process flow of clinic 
visits in relation to specific chemotherapy protocols in the outpatient pediatric oncology clinic at 
the Hospital for Sick Children in Ontario, Canada. Their findings identified several factors that 
contributed to prolonged wait times including extended registration process, delays in obtaining 
laboratory studies and preparing chemotherapy, inadequate nursing resources, and space 
constraints. Based on their assessment, a project studying a nurse-run express chemotherapy 
clinic was piloted for 76 patients who met outlined criteria. Evaluations were completed by 46 of 
the 76 enrolled families (61% response rate). Eighty-nine percent of families felt they always or 
usually received chemotherapy in a timely manner through the express chemotherapy clinic and 
almost all families reported that the express track improved clinic efficiency.  
Kallen et al. (2012) found that extensive wait time was a primary source of patient 
dissatisfaction within the network of six outpatient oncology treatment centers at the MD 
Anderson Cancer Center. The team observed all appointment-related events for 1,303 visits over 
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a one-month period using an appointment tracking and measurement system. They also 
conducted interviews with various staff members to explore their perception of patient 
throughput. Based on their assessment, an intervention study was implemented which utilized a 
fast track room to improve efficiency for patients with shorter infusions. A new communication 
system to obtain chemotherapy orders more quickly from physicians was executed. Additionally, 
an information technology-based communications application for notification of chemotherapy 
preparation was created for pharmacy. There was a 26.8% mean reduction in wait time post-
intervention based on analysis of 1,224 appointments during the one-month intervention period. 
Gjolaj et al. (2014) developed a process flow diagram of their outpatient oncology 
infusion center, and based on 59 visits over three months, were able to identify that laboratory 
turnaround time contributed to delays. A root cause analysis was conducted to determine process 
changes that could optimize laboratory operations. Phlebotomy processes were streamlined by 
creating a dedicated phlebotomy station in the clinic. The number of process steps were reduced 
from eight to four, laboratory tubes were upgraded, and the procedure for sending samples to the 
laboratory was modified. These changes decreased laboratory turnaround time by 53% and total 
wait time by 17% in a sample of 59 appointments over a nine-week intervention phase. 
These outpatient oncology clinics’ experiences highlight the importance of conducting a 
thorough evaluation of patient throughput to develop a targeted action plan to improve clinic 
efficiency. Baseline data provides a foundation for process improvement projects by identifying 
areas that contribute to delays and recognizing non-value-added work. The data is used to 
compare the outcomes post process improvement. The action plan for each cancer center in the 
literature was unique and based upon the initial evaluation of clinic processes. The evaluation is a 
critical step that must be carried out to ensure success of the project (Belter et al., 2012).  
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Most studies in the literature that were conducted with the goal of improving outpatient 
cancer center efficiency utilized simulation to determine resource utilization, map clinic 
performance, and find the best scheduling method. Ahmed, ElMekkawy, and Bates (2011) tested 
several scheduling templates in patients receiving chemotherapy to determine which served the 
most patients while using resources most efficiently. Woodall et al. (2013) used a simulation-
optimization model which indicated that adjustment of nurse schedules according to patient 
volume and adding part-time nurses would have the largest impact on wait times. Studies by 
Chabot and Fox (2005) and Cusack, Jones, and Chisholm (2004) focused on creating patient 
acuity classification systems to guide staffing needs, scheduling, and resource allocation to 
improve clinic efficiency.  
In total, there were 56 studies identified that focused on simulation, scheduling, and 
staffing modifications to optimize patient throughput. Only 13 studies focused on analysis of the 
current clinic state without simulation, and subsequent development of an action plan based on 
the findings. Our study helped to fill this gap in the literature by conducting a systematic 
assessment of patient throughput to identify patient and clinic factors that contribute to delays 
and then developing a targeted plan to improve patient throughput and efficiency.  
Theoretical Framework 
Lean transformation is a framework that focuses on maximizing value and minimizing 
non-value-added waste (Lean Enterprise Institute, 2018). There is an emphasis on optimization of 
the flow of services through the entire value stream rather than on individual parts of the system. 
This strategy was initially developed to improve manufacturing by Toyota Motor Company in 
the 1980s and has since been applied in many settings including various businesses and 
industries, government organizations, and healthcare (Lean Enterprise Institute, 2018). In 
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healthcare, this system can be used to eliminate non-value-added steps and streamline patient 
visits to optimize efficiency, improve safety, and thereby reduce wait times and increase patient 
satisfaction. Many healthcare organizations have used lean transformation to improve care 
delivery (Belter et al., 2012; Gjolaj et al., 2016; Wineke, Goedbloed, & van Harten, 2009).  
The many steps and departments involved in an outpatient oncology clinic visit create 
opportunity for errors, corrections, and miscommunication which leads to potential for increased 
patient wait time, inefficient allocation of staff resources, drug waste, and increased costs (Belter 
et al., 2012). The goal of using the lean transformation framework in our outpatient pediatric 
clinic was to evaluate our current processes and identify opportunities to improve coordination of 
care, eliminate waste, and ultimately improve patient throughput.  
There are five principles to guide the implementation of a lean transformation (Figure 1). 
The first is to identify value from the perspective of the consumer and organization. For our 
project, value was defined as decreased wait time and improved clinic efficiency. The second 
phase is to map the value stream and identify non-value-added steps which cause delays and can 
be eliminated (Lean Enterprise Institute, 2018). Within the framework, the process by which an 
organization identifies, understands, and responds to challenges begins with gaining a deep 
knowledge of the situation (Shook, 2010). This is the step upon which our study concentrated.  
The third phase is to create flow by implementing changes that add value, increase 
efficiency, and improve throughput based on findings from our analysis. The next step of the 
process is to allow the staff and patients to pull value from the new flow. An analysis of the new 
system will take place and additional areas for improvement will be identified. The process is 
continuous and repeats with the goal of maximizing value and minimizing waste. Our study was 
guided by the lean transformation process by evaluating the current state of patient throughput in 
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the pediatric hematology, oncology, and BMT clinic as the first step to improving efficiency 
(Lean Enterprise Institute, 2018).  
Study Variables 
 The independent variables for our study focused on patient and appointment factors that 
may impact patient throughput. The dependent variables measured throughput times at each 
intersection during the clinic visit and total throughput time. Additional qualitative variables 
measured the clinic staff’s overall assessment of patient throughput and what the staff thought 
might be done to improve throughput. Refer to Table 1 for a full description of study variables.  
Methods 
Research Design 
We conducted a descriptive-comparative study to analyze patient throughput in the 
pediatric hematology, oncology, and BMT clinic. Four time intervals throughout the clinic visit 
were measured to identify the intersections that cause delays. Patient information and details 
about the visit were also collected to determine patient-specific and appointment-specific factors 
that impact throughput. The data were obtained through retrospective chart reviews. Prospective 
data were obtained from clinic staff through two survey questions focusing on their opinion of 
clinic throughput and what may be done to improve throughput.  
Study Sample 
The target sample was children, adolescents, teenagers, and young adults with 
hematologic and oncologic conditions who received care at the pediatric hematology, oncology, 
and BMT outpatient clinic. Patients treated at the clinic range from less than one year old to late 
20s. Conditions treated at the clinic consist of hematologic malignancies, solid tumors, and 
neurological cancers. Non-malignant hematologic conditions treated include sickle cell anemia, 
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hemophilia, and thrombosis. The clinic also provides care for patients who have undergone BMT 
for treatment of an oncologic or non-malignant disease. Additional oncologic and hematologic 
diagnoses aside from those listed are also treated.  
 The most common types of appointments that occur in clinic include: (a) provider visit, 
laboratory studies, and infusion; (b) provider visit, laboratory studies, and blood product 
transfusion; and (c) provider visit and laboratory studies.  
 Clinic staff that were invited to participate in the survey questions included those that 
provide direct care to patients as they move through the various intersections of a clinic visit. The 
people in these roles are best able to understand and analyze clinic throughput.  
Inclusion and Exclusion Criteria 
We included all patients, including male, female, and all races, seen at the clinic who met 
inclusion criteria. Patients were included if they met the following criteria: (a) were of any age 
and being seen at the clinic, (b) had a hematologic or oncologic diagnosis, (c) were receiving 
chemotherapy or biotherapy, (d) were receiving non-chemotherapy infusions or treatments, (e) 
were receiving blood product transfusions, (f) were receiving any combination of treatments, (g) 
were scheduled or walk-in patients, and (h) were being admitted to the hospital from clinic.  
Patients excluded from the study were those who had the following: (a) a procedure 
scheduled during the clinic visit (i.e. bone marrow biopsy or lumbar puncture), (b) a diagnostic 
test scheduled during clinic visit (i.e. CT scan or echocardiogram), (c) an appointment to see the 
provider and/or have a treatment without laboratory studies, (d) treatment scheduled that was not 
contingent upon laboratory results from that day, and (e) repeat visits for a single patient. Patients 
with tests and procedures were excluded because the tests may have occurred during the visit 
before the initiation of treatment and created inaccurate representation of throughput. Patients 
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without laboratory studies were excluded because these types of appointments rarely occur and 
the lack of time measurement for laboratory studies may have skewed the overall assessment of 
throughput. The three most common types of appointments were included in the analysis of 
throughput: (a) provider visit, laboratory studies, and infusion; (b) provider visit, laboratory 
studies, and blood product transfusion; and (c) provider visit and laboratory studies.  
Clinic staff included the following: (a) physicians, fellows, advanced practice nurses, 
nurses, nursing attendants, or certified medical assistants; (b) individuals providing direct 
medical, nursing, or supportive care to patients throughout all phases of the clinic visit; and (c) 
individuals able to read and write in English.  
Clinic staff were excluded if they met the following criteria: (a) worked in the clinic for 
less than six months, (b) did not provide direct care to patients, or (c) did not interact with 
patients throughout all clinic intersections.  
Sample Size 
On average, 40-50 patients are seen per day at the pediatric clinic and 20 of those patients 
receive a treatment. The clinic is open Monday through Friday and closed on weekends and 
holidays. Approximately 200-250 patients are seen per week and 100 patients receive treatments.  
A random sample of patients with appointments between November 1, 2017 and April 30, 
2018 was analyzed. An analysis of variance (ANOVA) was used to compare the means of the 
time intervals throughout the clinic visit for each appointment type and appointment time. For 
three groups, assuming a small effect size (eta-squared of 0.03), power of 80%, alpha of 0.05, a 
minimum sample size of 105 was needed. To gain a complete understanding of clinic throughput 
with an adequate number of each appointment type, the goal sample size was increased to 312, 
aiming to collect a balanced number of subjects in each of the three appointment categories.    
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There are approximately 125 staff members that work in the pediatric hematology, 
oncology, and BMT clinic. Of those, 48 staff members are in a medical, nursing, or supportive 
staff role and interact with patients throughout the phases of the clinic visit. The convenience 
sample of 48 staff members was invited to participate in the survey regarding clinic throughput. 
The survey was distributed between September 10, 2018 and November 1, 2018.  
Recruitment of Subjects 
Participants for the retrospective chart reviews were identified through historical schedule 
information from November 1, 2017 to April 30, 2018. During the twenty-six-week study period, 
patients were randomly selected from the schedule, starting with the first scheduled day each 
week, to reach the total sample size. Starting from November 2017, a patient was chosen at 
random and every tenth patient was assessed for eligibility for inclusion in data analysis. This 
process continued until the goal sample size was reached. 
An email was sent to all 48 staff members that met inclusion criteria explaining the 
purpose of the study and inviting them to participate in the survey. The institution required that 
an information sheet, including the consent statement, be provided to survey participants. This 
information sheet was incorporated in the e-mail invitation to participate in the survey as well as 
a link to complete the survey. Follow up emails were sent weekly through the end of the data 
collection period. The goal response rate for survey completion was 50%.  
Setting 
 The clinic is a combination physician office and infusion center. Depending on the 
patients’ needs and type of appointment, patients may have laboratory studies drawn, see the 
provider, and receive treatment in one location during their visit. Providers at the clinic include 
physicians, fellows, and advanced practice nurses. Registered nurses access central lines, draw 
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laboratory studies from CVCs, place peripheral intravenous lines, administer medications 
including chemotherapy and blood products, and provide supportive care. Support staff include 
nursing attendants who assess vital signs and provide supportive care; and certified medical 
assistants who perform phlebotomy, assess vital signs, and provide supportive care. 
Patients check-in at the front desk upon arrival at the pediatric cancer center, which then 
generates their identification band and signals the start of their visit. Patients wait in the waiting 
room until called into the triage area where vital signs are assessed. The phlebotomy room for 
peripheral laboratory studies is located within the clinic treatment area. The cancer center 
pharmacy prepares our clinic patients’ chemotherapy and other medications. The laboratory in 
the cancer center processes most studies drawn in the clinic, although some specialized studies 
are sent nearby to the main hospital laboratory. The blood bank is located across the street in the 
main hospital and blood products for clinic patients are obtained by a courier.  
Instruments and Measurement 
 All study data were entered in a Microsoft Excel spreadsheet. Data were extracted 
manually through retrospective chart reviews. Demographic information (i.e. age and sex), 
clinical information (i.e. diagnosis and route of laboratory studies), and appointment information 
(i.e. appointment type and appointment time) were obtained from the electronic medical record 
(EMR). Time intervals were calculated in minutes based on defined time points for the four 
clinic intersections (Table 1) and were extracted from the EMR. Patients were immediately 
coded upon data extraction by linking medical record number to a participant identification 
number in the Excel spreadsheet. The code sheet linking the two numbers as well as the Excel 
spreadsheet were stored on an encrypted thumb drive. Once data collection was complete, the 
code sheet was deleted. 
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 The prospective staff survey included four multiple choice demographic questions about 
age range, gender, job title, and number of years working in the clinic. Participants were also 
asked two open-ended questions regarding patient throughput. The first question asked, “What is 
your overall opinion of patient flow in the clinic? Patient flow is defined as: The movement of 
patients through the various phases of their clinic visit starting with check-in, triage, attainment 
and resulting of laboratory studies, and ending with either treatment initiation or provider visit (if 
no treatment is required)”. The second question asked, “Please share your opinion about what 
could be done to improve patient flow in our clinic” (see Appendix A for survey).  Responses 
were exported from Qualtrics to Excel for data analysis.  
Data Collection Procedure 
Patient-specific, appointment-specific, and clinical data were collected through 
retrospective review of the EMR. Data were obtained from header of the EMR, provider and 
nursing progress notes, medication administration record, and flowsheets. The time of scheduled 
appointment and time of check-in were found in a separate electronic system which manages the 
schedule. The student investigator of the study collected all data. 
 Time intervals between clinic activities were measured in minutes based on time points at 
the various intersections. Our cancer center has a two-part check-in process which involves two 
computer systems; one of which generates the identification band, and one that generates the bill. 
Our study measured check-in time from the system that generated the bill. Time at triage was 
specified by the time when triage vital signs were entered in the EMR. Time that laboratory 
studies were received was based on the time stamp on the result in the EMR. Time of treatment 
initiation was recorded based on the time that the medication was signed in the EMR or the time 
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that the blood product was started as documented in the transfusion note. Time intervals between 
each clinic activity were calculated separately and added together for total throughput time.  
 Demographics and qualitative information from clinic staff regarding their opinion about 
patient throughput were obtained through survey questions on Qualtrics between September 10, 
2018 and November 1, 2018. Responses were read and analyzed by the student investigator and 
validated by a second reader. 
 Data collection by one person was reasonable in this study because the sample size was 
not too large. Using one person for data collection helped to ensure consistency in the data that 
was retrieved.  
Data Analysis Plan 
 Data were entered in the Microsoft Excel spreadsheet by the student investigator. Data 
from the Qualtrics survey were exported into Excel at the completion of the data collection 
period. To ensure accuracy of data entry, 10% of the data was randomly selected to be double 
checked by a second student investigator who was familiar with the institution’s EMRs and had 
completed the Collaborative Institutional Training Initiative (CITI) program. The accuracy check 
was performed in October 2018. Inaccurate data were flagged by the reviewer and subsequently 
reviewed by both parties together. One incorrect entry was identified and corrected. Following 
collection of all data and the accuracy check, the data were exported from Microsoft Excel to 
IBM SPSS 25, which was used for data analysis.  
Descriptive statistics were performed for each variable. Descriptive statistics were used to 
address research questions one through four which assessed the average time intervals between 
each clinic intersection. Mean, standard deviation, minimum and maximum times were examined. 
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In addition, the distributions were examined using skewness and histogram with normal curve 
imposed, and outliers were identified.  
ANOVA was used to assess research questions five and six, which analyzed whether 
there was a difference in the total mean throughput time based on appointment type or 
appointment time. Post-hoc analyses were calculated using the Scheffe test to identify mean 
group differences by appointment type and appointment time. The level of significance was set at 
0.05. 
A qualitative assessment of survey responses was performed for research questions seven 
and eight to identify recurring phrases and themes about staff’s opinion of patient throughput and 
what might be done to improve throughput. First, the student investigator read all the survey 
responses to get a general sense of the information. Next, the data were hand-coded into 
categories by similar phrases and organized in an Excel spreadsheet. Based on the recurring 
phrases, themes were identified. A second student investigator also read the survey responses and 
validated the themes. The findings of the analysis were described in narrative form.  
Research Ethics 
 Our study received Institutional Review Board (IRB) expedited approval from the 
medical center where research took place as well as The George Washington University. 
Participation in the staff survey was voluntary and participants opened the survey through an 
anonymous link. Responses were accessible only by the student investigator. Once data were 
exported from Qualtrics to Excel, the data were stored on an encrypted thumb drive.   
 Patient medical record numbers were assigned a participant identification number, which 
was used in the Excel data spreadsheet immediately upon data extraction. The code sheet linking 
the two numbers was stored on an encrypted thumb drive and once data collection was 
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completed, the code sheet was deleted. Patient data were stored in an Excel spreadsheet on an 
encrypted thumb drive. The SPSS data files were also stored on an encrypted thumb drive.  
Results 
Retrospective Chart Reviews 
Demographic and clinical patient characteristics. For the total sample of 312 patients 
(Table 2), most were between the ages of three and 17 (n = 222; 71.2%). The majority of patients 
were male (n = 165; 52.9%). Most patients had a hematologic malignancy (n = 79; 25.3%) or 
non-oncologic hematology diagnosis (n = 130; 41.7%). Peripheral venipuncture was the most 
common route of laboratory studies (n = 217; 69.6%). 
 Average time between clinic intersections. To address research questions one through 
four, the mean time in minutes and standard deviation between specified clinic intersections were 
calculated (Table 3). The shortest interval was check-in to triage with a mean time of 18.49 ± 
18.21 minutes. The intention was to measure check-in to triage time for every patient, however it 
was discovered upon data collection that 89 patients were triaged before check-in. Of those 89 
patients, 46.1% were receiving infusions or blood product transfusions and 54% were having a 
provider visit and laboratory studies only. Of note, 59.6% of the patients who were triaged before 
check-in had appointments between 8:00 and 10:00 a.m. Therefore, the mean check-in to triage 
interval was calculated for the 223 patients who followed the intended sequence. The mean time 
from triage to receiving laboratory results was 94.19 ± 61.92 minutes. The longest time interval 
was between receiving laboratory results to treatment initiation with a mean time of 136.73 ± 
77.98 minutes. The total mean clinic throughput time was 146.03 ± 89.60 minutes.  
 Difference in total throughput time by appointment type. For the total sample of 312 
patients (Table 2), most had appointments consisting of provider visit and laboratory studies only 
PATIENT THROUGHPUT  22 
 
(n = 222; 71.2%) followed by provider visit, laboratory studies, and infusions (n = 58; 18.6%), 
with the fewest consisting of provider visit, laboratory studies, and blood product transfusions (n 
= 32; 10.3%). To address research question five, a one-way ANOVA was conducted to evaluate 
differences in total throughput time based on the type of appointment (Table 4). The shortest 
total mean throughput time was found in the provider visit and laboratory studies only group 
(115.53 ± 71.36 minutes) while the longest was the provider visit, laboratory studies, and blood 
product transfusion group (230.84 ± 105.08 minutes). The difference in total mean throughput 
time for the three appointment types was statistically significant (F = 62.67; p < .001). Scheffe 
post hoc analyses indicated that throughput time was significantly shorter for appointments 
consisting of provider visit and laboratory studies only compared to visits involving infusions (p 
< .001) and blood product transfusions (p < .001). There was no significant difference in 
throughput time between infusion appointments and blood product transfusion appointments. 
 Difference in total throughput time by appointment time. The majority of 
appointments were between 8:00 and 10:00 a.m. (n = 124; 39.7%) and 10:01 a.m. to 12:00 p.m. (n 
= 100; 32.1%). The lowest volume was between 12:01 and 2:00 p.m. (n = 40; 12.8%). Between 
2:01 and 6:00 p.m. there were 48 appointments (15.4%; Table 2). To assess research question six, 
we evaluated differences in total throughput time based on appointment time using a one-way 
ANOVA. The shortest total mean throughput time was in the 2:01 to 6:00 p.m. group while the 
longest was in the 8:00 to 10:00 a.m. group (Table 4). The differences in total mean throughput 
time for the four appointment times was statistically significant (F = 4.01; p = .008). Scheffe post 
hoc analyses indicated that throughput time for appointments between 8:00 and 10:00 a.m. 
(162.26 ± 103.68 minutes) was significantly longer than appointments between 2:01 and 6pm 
(112.48 ± 58.28 minutes; p = .013). The other appointment times were not statistically different.   
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Prospective Staff Survey 
Staff survey participant demographic and role characteristics. There were 22 of 48 
eligible staff members who responded to the survey (46% response rate; Table 5). The majority 
of respondents were registered nurses, medical assistants, and nursing attendants (n = 9; 40.9%), 
and advanced practice nurses (n = 7; 31.8%). Most respondents had worked in the clinic for over 
10 years (n = 14; 63.6%) or between 1 and 5 years (n = 7, 31.8%). Almost all respondents were 
females (n = 21; 95.5%) and most were between the ages of 21 and 51 (n = 12, 54.6%) years old.  
 Clinic staff overall assessment of patient throughput. The first open-ended question on 
the staff survey assessed research question seven. Overall, staff believed that patient throughput 
was suboptimal. Four people referred to throughput as inefficient. Three responses indicated that 
the clinic flow was poor. Other responses described throughput as complicated, illogical, 
inconsistent, and fair at best. Respondents noted that the flow is contingent upon several 
variables and that bottlenecks form at both check-in and triage. Several staff commented that the 
current process could be improved.  
 Clinic staff opinion about what might improve throughput. Research question eight 
was assessed by the second open-ended survey question. Problems that contributed to throughput 
inefficiencies and delays as well as solutions for improvement were identified and could be 
organized into seven themes (Table 6). The most commonly cited problem was non-compliance 
with appointment time (n = 14; 63.6%). Respondents explained that patients frequently arrived at 
clinic several hours before or after their specified appointment time and were still 
accommodated, which significantly impacted the clinic flow and wait times. A solution 
recommended by several staff was that appointment times should be strictly enforced, and if 
PATIENT THROUGHPUT  24 
 
medically safe, patients should be rescheduled when they are late. Phone calls reminding patients 
of their appointment date and time was another proposed solution.    
 The second most commonly occurring problem was laboratory processes (n = 12; 54.5%). 
Specifically, issues surrounding ordering laboratory tests were cited several times. Staff proposed 
requiring orders to be placed in advance and to revise the procedure for same-day ordering when 
necessary as a solution. Another problem was the workflow for drawing blood. Recommended 
solutions were to assign a designated CVC nurse and a dedicated phlebotomist without 
additional clinic responsibilities. Issues locating the laboratory requisitions were also discussed 
as cause for laboratory delays and creating a standard method to organize the requisitions was a 
recommendation for improvement.   
 It seemed to be the consensus that the front desk staff played an important role in clinic 
functionality, but problems with the front desk workflow and check-in process were cited 10 
times (45.4%) in survey responses. Specifically, respondents noted that there was a lack of 
accountability, collaboration, and leadership with front desk staff which contributed to 
dysfunction at this clinic intersection. Another problem was that there was a two-part check in 
process; one to generate an identification band, and one to generate a bill. Recommended 
solutions were to simplify this process to one step and to actively involve the front desk 
leadership in daily operations and clinic meetings.  
Triage workflow was another problem identified in the surveys (n = 8; 36.3%). Limited 
space in triage causing a bottleneck was mentioned several times, as well as the recommended 
solution to expand the area, creating the ability to simultaneously triage multiple patients. 
Another suggestion to improve efficiency was to modify the documentation process to eliminate 
paper and allow for vital-sign entry into the EMR only.  
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 Physician timeliness was a problem that was mentioned seven times (31.8%). Physicians 
arrived late to clinic and did not see patients based on their appointment times. Respondents 
suggested that when physicians are scheduled in clinic, they should not also be scheduled to 
perform procedures in the operating room. Another issue was fellow and advanced practice nurse 
scheduling and duties (n = 5; 22.7%). Staff reported that the fellows transitioning from covering 
the oncology service in the morning to the hematology service in the afternoon contributed to 
significant inefficiency. A suggestion for resolution was that fellows do not cover both services 
on the same clinic day. Additionally, advanced practice nurses’ schedules did not align with 
clinic needs. A recommendation for improvement was to schedule more advanced practice 
nurses on days when clinic volume is typically higher. Saving seats in clinic was an issue which 
was mentioned four times (18.1%). Patients often saved infusion chairs before they were ready to 
receive their treatment which created congestion and chaos in the treatment area. A proposed 
solution was to restrict this practice to improve clinic flow.  
Discussion 
 We assessed four time intervals between clinic intersections to determine where delays 
were occurring during clinic visits. The findings indicated that the mean time from check-in to 
triage was reasonable. Conversely, check-in and triage were cited in the staff survey as major 
areas of bottlenecking and delays in the clinic. Notably, when collecting the data, we realized that 
many patients were triaged before being checked-in. Upon further evaluation, we discovered that 
the two-step check-in process was the most likely cause for this discrepancy in the expected 
sequence of clinic events.  
The clinic uses two separate computer systems for check-in purposes. A patient is 
checked-into one system to generate their identification band and the second system generates 
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their bill after the visit. In our study, we measured check-in time from the system that generates 
the bill. The staff member that manages the billing system did not start work until 9:00 a.m., 
which caused a delay in the check-in time for patients who had appointments between 8:00 and 
9:00 a.m. Of note, the billing check-in did not delay the start of the clinic visit and was only 
required to generate the bill afterward. Another reason that triage occurred before check-in was if 
a patient arrived who required immediate medical attention. These patients bypassed the billing 
check-in station and were escorted to the treatment area to be assessed. Patients that did not 
follow the intended sequence of check-in followed by triage were excluded from the check-in to 
triage time assessment. Based on these discovered complexities and disorganization, check-in 
and triage are likely two areas of clinic that contribute to substantial inefficiency.  
Our findings also indicated that the process of drawing laboratory studies and obtaining 
results contributed to delays in clinic. There were laboratory delays, although not perversely long. 
Therefore, the time interval for this clinic intersection may represent the typical time required to 
perform the necessary tasks and process the laboratory studies to some degree. However, it is 
expected that the throughput results for this clinic intersection reflect instances when tests were 
not ordered the day before the visit, there were delays in drawing blood, there were interruptions 
in processing samples in the laboratory, and requisitions were not organized. There were likely 
instances when the providers may have had the ability to identify potential for delays in the 
laboratory process in real-time and intervene to correct the issue. In these cases, the disruption in 
provider workflow could have potentially contributed to delays later in the visit due to 
unexpected redistribution of staff resources.  
The literature revealed that laboratory processes were a commonly identified issue which 
contributed to delays in outpatient cancer centers (De Pourcq et al., 2018; Gjolaj et al., 2014; 
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Gjolaj et al., 2016; Hendershot et al., 2015). Eliminating laboratory studies on the day of 
treatment could reduce the number of process steps in a clinic visit, which was the approach used 
by Gjolaj et al. (2016) to improve their clinic flow. Gjolaj et al.’s (2016) team identified patients 
that were eligible to have orders signed and laboratory studies completed the day prior to 
treatment. Using the expedited workflow process, there was a decrease of 17 minutes in mean 
wait time and a 17% increase of value-added time for 527 eligible patient visits over a five-
month period. Similarly, De Pourcq et al. (2018) compared throughput times for patients having 
laboratory studies drawn the day before versus the day of treatment for 243 visits at two 
outpatient chemotherapy centers. There was a statistically significant decrease in mean 
throughput time of 53 minutes for patients whose laboratory studies were drawn the day before 
treatment. Drawing blood in advance of the treatment day requires additional travel and time 
commitment from the patient, however, this process could be coordinated with a laboratory or 
physician office closer to home. Additionally, the improvement in patient experience the day of 
treatment may outweigh the inconvenience of the added visit.  
The longest interval in our study was the time from receiving laboratory results to 
treatment initiation, which encompassed the time required for providers to clear the patient for 
treatment, the time for pharmacy or blood bank to prepare and dispense medication or blood 
product, and the time for the registered nurse to initiate therapy. As expected, we found that 
appointments with provider visit and laboratory studies only were significantly shorter than those 
with infusions or blood product transfusions, as the infusions and transfusions required additional 
preparation. Notably, there was no significant difference in throughput time between infusion and 
blood product transfusion appointments, which indicated that the blood bank and pharmacy had 
comparable preparation times. Neither pharmacy nor blood bank processes were recognized as 
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areas which contributed to clinic inefficiencies on our staff survey. However, the identified staff 
survey themes of physician timeliness, and fellow and advanced practice nurse scheduling and 
duties likely contributed to delays in evaluating and clearing patients for treatment.  
Soh et al. (2015) tested the impact of preparing chemotherapy the day before scheduled 
treatment on throughput times. They found that preparing chemotherapy in advance depended 
upon drug stability, cost, and the patient’s ability to complete laboratory studies in advance of the 
visit. Soh et al. (2015) found that mean wait times were reduced by 66% from 65.74 minutes to 
22.44 minutes over the six-month study period by preparing chemotherapy in advance of the 
visit. Notably, there were no drug wastages. Eliminating time spent waiting for laboratory results 
and drug preparation would likely significantly reduce throughput time and streamline flow.   
 Our findings indicated that appointments scheduled between 8:00 and 10:00 a.m. were 
significantly longer than those between 2:01 and 6:00 p.m. The most frequent appointment time 
was 8:00 to 10:00 a.m. and the majority of all appointments were scheduled between 8:00 a.m. 
and 12:00 p.m. The sheer volume of patient appointments scheduled during the morning hours 
likely contributed to clinic congestion and delays. Suss et al. (2017) used a discrete event 
simulation model to develop a scheduling algorithm for their outpatient cancer center to optimize 
resource utilization and decrease patient throughput times. Specifically, they adjusted the order 
and rate that patients arrived for appointments based upon projected length of appointment and 
required resources. The algorithm alone decreased wait time by 25%. When they incorporated 
interventions to reduce pharmacy delays for order clarification from 33% to 10%, the average 
overall wait time decreased by 44%. These reductions in wait time highlight the benefit of 
strategic scheduling and the impact that it can have on overall clinic functionality. 
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Despite careful scheduling, noncompliance with appointment time is a factor that can 
perpetuate disorganization and inefficiencies. Although noncompliance was the most commonly 
cited theme in our staff survey, we did not measure data on compliance with scheduled 
appointment time in our study. Skeldon et al. (2014) identified appointment lateness as a factor 
that contributed to wastefulness in their uro-oncology clinic and therefore implemented 
telephone and e-mail appointment confirmations. The reminders in combination with other 
modifications to clinic workflow significantly reduced mean clinic throughput time from 46 
minutes at baseline to 35 minutes at 60 days (p < .001) and 41 minutes at 90 days (p = .051).  
 Our study revealed that clinic throughput was perceived as generally suboptimal by the 
staff. The identified themes supported the data that we collected which identified congested 
clinic intersections including check-in at the front desk, triage, and the laboratory. The dual-
check-in process and lack of accountability of the front desk staff were identified as problems 
that could be addressed to improve efficiency. Bottlenecks at triage due to lack of space were 
also recognized as problems which contributed to delays. Laboratory orders not being placed in 
advance, prolonged wait time for blood to be drawn, and disorganization of laboratory 
requisitions were issues identified by staff that should also be corrected. Physicians being late to 
clinic and being scheduled for procedures during clinic hours were problems that staff identified 
as contributing to delays. Advanced practice nurses’ schedules being misaligned with clinic 
volume needs and fellows switching services between oncology and hematology midday were 
also issues that staff felt contributed to clinic inefficiencies. Staff also described patients “saving 
seats” in the treatment area before they were ready to receive their therapy as an issue that 
caused congestion and chaos. Each of these identified problems had associated solutions which 
could potentially improve clinic efficiency and reduce throughput times.  
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Study Limitations 
 A limitation of this study was the inability to obtain a balanced sample size in the three 
appointment type categories because we excluded repeat clinic patients. Most patients receiving 
infusions and blood product transfusions returned to clinic during the study period but could be 
included in analysis only once, which resulted in smaller sample sizes in the infusion and blood 
product transfusion groups. Another limitation is that we did not measure data on compliance 
with appointment time. Understanding the volume of noncompliant patients would lend insight 
to the impact of this issue on clinic functionality.  
Additionally, we did not collect information about time from patient clearance for therapy 
to treatment initiation. This time interval would directly reflect pharmacy and blood bank 
preparation time and highlight potential delays due to their workflows. The time interval that we 
studied, from laboratory results being received to treatment initiation, encompasses the time 
required for patients to be assessed by the provider. Therefore, it is not clear whether the time 
span reflects provider, pharmacy, or blood bank delays.  
Another limitation is that we did not measure the time interval between laboratory studies 
being collected and receiving study results. This time interval would directly correlate with 
internal laboratory processes which may or may not contribute to delays. Rather, we measured 
the time from triage to laboratory studies being available, which could potentially encompass a 
delay in laboratory studies being drawn after triage occurred. Additionally, we did not collect 
information about whether laboratory studies were ordered the day before the treatment. 
Understanding the volume of same-day laboratory orders would have been useful in identifying 
the impact of advanced laboratory ordering on throughput.  
Implications/Recommendations for Practice, Policy, and Research 
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 Delays occurred at each clinic intersection and staff identified specific issues as well as 
overarching problems which contributed to clinic inefficiencies. We intend to implement targeted 
interventions via a structured action plan to address the most significant issues to reduce delays 
at each clinic intersection. The first step of translating the study findings into practice and 
developing recommendations to address throughput issues is to present our results to the clinic 
staff and leadership team. The primary focus of this presentation is to generate discussion about 
the findings and reach consensus about the clinic’s top priority throughput issues and how to 
correct them. To manage delays and disorganization at the front desk, we recommend that the 
check-in process be simplified to one-step which will generate both the identification band and 
the patient bill. We also suggest that front desk leadership be included in routine meetings and 
communication regarding clinic operations in order to improve accountability and collaboration 
with clinic staff. To address the problem of noncompliance with scheduled appointment time, we 
favor the implementation of appointment reminder text messages sent electronically through the 
EMR. We suggest that clinic leadership develop a protocol to manage patients who arrive late or 
early for their scheduled appointment time. Additionally, we recommend that clinic leaders 
collaborate with schedulers to strategically arrange patients more evenly throughout the day to 
alleviate the volume between 8:00 a.m. and 12:00 p.m.  
 To reduce bottlenecks at triage, we support creating a second triage space to 
simultaneously triage patients and expedite throughput at this intersection. Laboratory results 
could be expedited by facilitating more timely blood draws. Therefore, we recommend that the 
phlebotomist not be assigned additional clinic duties, especially between the busiest hours of 
8:00 a.m. and 12:00 p.m. Additionally, we favor printing laboratory requisitions each evening for 
the next clinic day to help maintain organization and simplify laboratory throughput. To improve 
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efficiency in assessing and clearing patients for treatment, we suggest eliminating the fellows’ 
mid-day change in service coverage. In doing so, the fellows would see strictly oncology or 
hematology patients during the clinic day, switching on a weekly basis. This schedule would help 
to avoid role confusion and facilitate continuity of care and undisrupted progression of patient 
flow during the clinic visit. In order to avoid congestion in the treatment area, we support 
restricting the practice of “saving seats” whereby patients would be seated in infusion chairs only 
when ready for treatment. Implementation of these interventions have the potential to increase 
the efficiency of clinic flow, reduce throughput times, and improve patient and staff satisfaction.  
 The findings of our study have added to the literature by supporting the need for a 
thorough evaluation of current clinic throughput to gain an understanding of areas that contribute 
to significant delays. Our study highlighted the value of this initial assessment and demonstrated 
the ability to utilize the information gained to develop an action plan to address the identified 
issues. Other outpatient cancer centers could use our study design to conduct a similar appraisal 
of their clinic throughput processes with the goal of using the knowledge to make valuable 
changes to improve efficiency.  
Sustainability 
 The interventions proposed in the action plan would not cost money to implement except 
for a new computer system to eliminate the two-part check-in process. However, the new EMR 
has already been purchased by the medical center and is in the process of execution. This EMR 
system would also enable the text message appointment reminders.  
 To obtain buy-in and engage the entire clinic team in the proposed changes, nursing, 
medical, and administrative leadership must unite and communicate a clear and consistent plan to 
their staff. A crucial aspect is to ensure that new processes are being adhered to, which will also 
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be the responsibility of the clinic leaders. Additionally, after implementation, a reevaluation of 
patient flow must be done to determine the effectiveness of the interventions. Obtaining feedback 
from the team is vital in order to identify details that may require modification to meet the needs 
of the clinic, team members, and patients. The cycle of reevaluation, modification, and 
implementation is necessary on an ongoing basis for the changes to be successful and lasting.  
Conclusions 
 Our study took the critical first step of performing a thorough evaluation of patient flow 
to identify areas of clinic that contribute to significant delays in order to develop an action plan 
to improve throughput. We found that delays occurred at each clinic intersection. The longest 
interval was from receiving laboratory results to treatment initiation and the shortest was from 
check-in to triage. Differences in throughput time by appointment type and appointment time 
were significant. Throughput time was significantly shorter for appointments consisting of 
provider visit and laboratory study only compared to visits involving infusions and blood product 
transfusions. Throughput for appointments between 8:00 and 10:00 a.m. was significantly longer 
than appointments between 2:01 and 6:00 p.m. Staff reported that throughput was suboptimal and 
identified issues at each clinic juncture as well as overarching problems that prolong wait time 
and cause inefficiencies. The most common problems they identified were appointment 
noncompliance, laboratory workflow, and bottlenecks at the front desk and triage. The identified 
issues will be addressed by implementing targeted interventions via a structured action plan to 
reduce delays at each clinic intersection. These interventions have the potential to increase the 
efficiency of clinic flow, reduce throughput times, and improve patient and staff satisfaction.  
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Table 1. Study Variables including Theoretical and Operational Definitions 
 






Patient age Demographic / 
Nominal  
Chronological age in 
years. 
1 = 0 to <3 years 
2 = 3 to <12 years 
3 = 12 to <18 years 
4 = ≥18 years  




1 = Male 
2 = Female 
Patient 
diagnosis 
Clinical / Nominal Medical diagnosis 
patient is being treated 
for at the clinic. 
Hematologic or oncologic 
condition that patient is 
being treated for at the 
clinic. BMT status if 
applicable.  Diagnosis also 
corresponds to which 
division and practitioners 
are seeing the patient.  
 
1 = Hematologic 
malignancy 
2 = Solid tumor 
3 = Neurological 
malignancy 
4 = BMT 





Clinical / Nominal  Route by which 
laboratory studies are 
obtained (peripheral 
venipuncture or via 
CVC) 
1 = Peripheral 
venipuncture 
2 = CVC 





Type of appointment 
that the patient is 
scheduled for at the 
clinic.  
Classification of 
appointment type based on 
services provided during 
that visit to the clinic.  
 
1 = Provider visit, 
laboratory studies, infusion 
treatment. 
2 = Provider visit, 
laboratory studies, blood 
product transfusion. 
3 = Provider visit, 
laboratory studies only.  
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What is the scheduled 
time of the patient’s 
appointment? 
1 = 8:00 a.m. - 10:00 a.m. 
2 = 10:01 a.m. - 12:00 p.m. 
3 = 12:01 p.m. - 2:00 p.m. 




Dependent / Interval  Measure of time from 
when the patient 
checks in at the front 
desk of the clinic to 
when they arrive in 
triage. This 
information is found 
in the scheduling 
EMR.  
Actual time measurement 
in minutes from when 
patient checks in at front 
desk of the clinic to when 






Dependent / Interval Measure of time from 
when the patient 
arrives in triage to 
when laboratory study 
results are posted in 
the electronic medical 
record. Triage arrival 
is determined by the 
time that triage vital 
signs are documented. 
This is found in the 
EMR.  
Actual time measurement 
in minutes from when the 
patient arrives in triage to 
when laboratory study 
results are posted in the 








Dependent / Interval  Measure of time from 
when the patient’s 
laboratory study 
results are posted in 
the medical record to 
the initiation of their 
treatment. Treatment 
initiation is 
documented in the 
medication 
administration record 
and in the blood 
product transfusion 
note depending on the 
type of treatment. This 
is done in EMR. 
Actual time measurement 
in minutes from when the 
patient’s laboratory study 
results are posted in the 
medical record to the 
initiation of their treatment 
or N/A. 
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Dependent / Interval Measure of time from 
when the patient 
checks in at the clinic 
front desk to the final 
phase of clinical visit.  
Actual time measurement 
in minutes from the first 
contact in clinic (check-in 
or triage) to the final phase 
of their clinic visit. Final 
phase of clinic visit will 
vary depending on 
appointment type.  




end with initiation 
of first treatment.  
b. For patients having 
a provider visit and 
laboratory studies, 
measurement will 
end with receipt of 
laboratory results. 
Staff role Demographic / 
Nominal 
Job title of the staff 
member in the clinic. 
A = Attending physician 
B = Fellow 
C = Advanced practice 
nurse 
D = Registered nurse, 







Number of years that 
staff member has been 
employed in the clinic. 
A = <1 year 
B = 1 to 5 years 
C = 6 to 10 years 
D = >10 years 




A = Male 
B = Female 
Staff age Demographic / 
Nominal 
Chronological age in 
years. 
A = 21 to <36 years 
B = 36 to <51 years 
C = 51 to <65 years 





Qualitative  Clinic staff’s overall 
assessment of patient 
throughput in the 
clinic.  
Staff were invited to 
describe their assessment 
of patient throughput in the 
clinic in their own words. 
Recurring ideas and 
themes were identified.  
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Qualitative  Clinic staff’s opinions 
about what could be 
done to improve 
patient throughput in 
the clinic.  
Staff were invited to 
describe their opinion 
about what might be done 
to improve throughput in 
the clinic in their own 
words. Recurring ideas and 
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Table 2. Demographic and Clinical Patient Characteristics 
 
Variables Freq (%) 
Age (years) 
 
 <3  58 (18.6) 
 3 to <12  135 (43.3) 
 12 to <18  87 (27.9) 
 ≥18  32 (10.3) 
Gender 
 
 Male 165 (52.9) 
 Female 147 (47.1) 
Diagnosis 
 
 Hematologic malignancy 79 (25.3) 
 Solid tumor 53 (17) 
 Neurological malignancy 16 (5.1) 
 BMT 34 (10.9) 
 Hematology (non-oncologic) 130 (41.7) 
Route of laboratory studies  
 Peripheral venipuncture 217 (69.6) 
 CVC 95 (30.4) 
Appointment type 
 
 Provider visit, laboratory studies, infusion treatment 58 (18.6) 
 Provider visit, laboratory studies, blood product transfusion 32 (10.3) 
 Provider visit, laboratory studies only 222 (71.2) 
Scheduled appointment time 
 
 8:00 a.m. - 10:00 a.m. 124 (39.7) 
 10:01 a.m. - 12:00 p.m. 100 (32.1) 
 12:01 p.m. - 2:00 p.m. 40 (12.8) 
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Table 3. Clinic Interval and Throughput Time in Minutes 
Time Variable N Mean (SD) Range 
Time from check-in to triage 223 18.49 (18.21) 1 - 159 
Time from triage to receiving laboratory results 312 94.19 (61.92) 6 - 568 
Time from receiving laboratory results to 
treatment initiation 
90 136.73 (77.98) 16 - 374 
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Table 4. Clinic Total Throughput Time by Appointment Type and Scheduled Appointment Time 
 
Variables Mean (SD) Statistics p value 
Appointment type   F = 62.67 < .001 





 Provider visit, laboratory studies, 




 Provider visit, laboratory studies only 115.53 (71.36) 
 
 
Scheduled appointment time 
 
F = 4.01 .008 
 8:00 a.m. - 10:00 a.m. 162.26 (103.68) 
 
 
 10:01 a.m. - 12:00 p.m. 147.29 (90.41) 
 
 
 12:01 p.m. - 2:00 p.m. 132.85 (53.59) 
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Table 5. Demographic and Role Characteristics of Staff Survey Respondents  
Variables Freq (%) 
Role  
 Attending Physician 4 (18.2) 
 Fellow 2 (9.1) 
 Advanced Practice Nurse 7 (31.8) 
 Registered Nurse, Medical Assistant, or Nursing Attendant 9 (40.9) 
Length of employment in clinic (years)  
 <1 0 (0) 
 1 to 5  7 (31.8) 
 6 to 10  1 (4.5) 
 >10  14 (63.6) 
Gender  
 Male 1 (4.5) 
 Female 21 (95.5) 
Age (years) 
 
 21 to <36  6 (27.3) 
 36 to <51  6 (27.3) 
 51 to <65  9 (40.9) 
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Table 6. Staff Survey Themes about Problems that Contributed to Throughput Inefficiencies and 
Delays 
Theme Occurrences in Survey  
N (%) 
Appointment time non-compliance   14 (63.6) 
Laboratory processes 12 (54.5) 
Front desk workflow   10 (45.4) 
Triage workflow 8 (36.3) 
Physician timeliness  7 (31.8) 
Fellow and advanced practice nurse scheduling/duties 5 (22.7) 






























Q1 Please select your job title. 
o Attending Physician   
o Fellow   
o Advanced Practice Nurse  
o Registered Nurse, Medical Assistant, or Nursing Attendant   
 
 
Q2 Please indicate the number of years you have worked in the outpatient pediatric hematology, 
oncology, and BMT clinic.  
o < 1 year  
o 1 to 5 years  
o 6 to 10 years  
o > 10 years   
 
 
Q3 Please select your gender. 
o Male   
o Female   
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Q4 Please select your age range. 
o 21 to < 36 years    
o 36 to < 51 years   
o 51 to < 65 years   
o > 65 years   
 
 
Patient Flow Assessment 
 
Q5 What is your overall opinion of patient flow in the clinic?  
Patient flow is defined as: The movement of patients through the various phases of their clinic 
visit starting with check-in, triage, attainment and resulting of laboratory studies, and ending with 




Q6 Please share your opinion about what could be done to improve patient flow in our clinic.  
________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
